San Diego-dependent Viking Therapeutics marked by itself as a serious competitor in the weight loss drug marketplace in February just after revealing promising info from a mid-phase trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when provided being a weekly injection and in March the company u… Read More